Metabolomics-Driven Exploration of the Chemical Drug Space to Predict Combination Antimicrobial Therapies
Authors:
Open Access
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Molecular Cell
- Vol. 74 (6) , 1291-1303.e6
Abstract
No abstract availableKeywords
Funding Information
- Worldwide Cancer Research (WCR-15-1058)
- UNAM-DGECI
This publication has 84 references indexed in Scilit:
- Systematic exploration of synergistic drug pairsMolecular Systems Biology, 2011
- Metabolite-enabled eradication of bacterial persisters by aminoglycosidesNature, 2011
- Resolution of Gene Regulatory Conflicts Caused by Combinations of AntibioticsMolecular Cell, 2011
- Phenotypic Landscape of a Bacterial CellCell, 2011
- Microtubule-binding agents: a dynamic field of cancer therapeuticsNature Reviews Drug Discovery, 2010
- Role of RpoS in Virulence of PathogensInfection and Immunity, 2010
- Circos: An information aesthetic for comparative genomicsGenome Research, 2009
- A domino effect in antifolate drug action in Escherichia coliNature Chemical Biology, 2008
- Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in miceProceedings of the National Academy of Sciences, 2008
- Construction of Escherichia coli K‐12 in‐frame, single‐gene knockout mutants: the Keio collectionMolecular Systems Biology, 2006